Marché européen du diagnostic du cancer gastrique – Tendances et prévisions du secteur jusqu’en 2030

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Healthcare IT Europe Gastric Cancer Diagnostics Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen du diagnostic du cancer gastrique – Tendances et prévisions du secteur jusqu’en 2030

  • Healthcare IT
  • Publish Reports
  • Mar 2023
  • Europe
  • 350 Pages
  • Nombre de tableaux : 250
  • Nombre de figures : 56
Buy Now Acheter maintenant

Europe Gastric Cancer Diagnostics Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
 2024 –2030
Diagram Taille du marché (année de référence)
 MILLIONS DE DOLLARS AMÉRICAINS
Demande
Diagram Taille du marché (année de prévision)
 Dollars américains 428.98
Diagram TCAC
 %
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>
Demande de déverrouillage

>Marché européen du diagnostic du cancer gastrique, par type de produit (instruments, réactifs et consommables, services), type de diagnostic (tests de dépistage du cancer gastrique (pré)/examen physique, tests de confirmation), groupe d'âge (adulte, pédiatrie et gériatrie), type (adénocarcinome intestinal ou diffus, tumeur carcinoïde, tumeur stromale gastro-intestinale (GIST), lymphome gastrique et autres), stade (stade 0, stade I, stade II, stade III), sexe (homme et femme), type d'échantillon (sang, tissu, urine et selles), utilisateurs finaux (laboratoires de diagnostic, hôpitaux, instituts de recherche sur le cancer, cliniques spécialisées en oncologie et autres), canal de distribution (appels d'offres directs et ventes au détail) Tendances et prévisions de l'industrie jusqu'en 2030.

Marché européen du diagnostic du cancer gastrique

Analyse et perspectives du marché européen du diagnostic du cancer gastrique

L'augmentation de la population gériatrique en Europe stimule la croissance du secteur du diagnostic du cancer gastrique. La prévalence des tumeurs et des lymphomes gastro-intestinaux a également stimulé la demande de diagnostics du cancer gastrique. La principale contrainte du marché est la nécessité de réduire les prix élevés associés aux tests de diagnostic du cancer afin que même les pays en développement puissent en bénéficier.

Marché européen du diagnostic du cancer gastrique

Marché européen du diagnostic du cancer gastrique

Un grand nombre d’acteurs du marché proposent des produits de diagnostic du cancer gastrique avec des innovations qui ouvrent la voie à la croissance du marché européen du diagnostic du cancer gastrique.

Selon les analyses de Data Bridge Market Research, le marché européen du diagnostic du cancer gastrique devrait atteindre la valeur de 428,98 millions USD d'ici 2030, à un TCAC de 8,1 % au cours de la période de prévision. Les réactifs et les consommables représentent le segment de type de produit le plus important du marché en raison de la demande croissante de kits et de réactifs, et l'augmentation des dépenses de santé a accéléré la demande de dispositifs médicaux intelligents.

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable de 2015 à 2020)

Unités quantitatives

Chiffre d'affaires en millions USD, volumes en unités, prix en USD

Segments couverts

Par type de produit (instruments, réactifs et consommables, services), type de diagnostic (test de confirmation, tests de dépistage du cancer gastrique/examen physique), groupe d'âge (adulte, pédiatrie et gériatrie), type de maladie (adénocarcinome intestinal ou diffus, tumeur carcinoïde, tumeur stromale gastro-intestinale (GIST), lymphome gastrique et autres), stade (stade 0, stade I, stade II, stade III), sexe (homme et femme), type d'échantillon (sang, tissu, urine et selles), utilisateurs finaux (laboratoires de diagnostic, hôpitaux, instituts de recherche sur le cancer, cliniques spécialisées en oncologie et autres), canal de distribution (appels d'offres directs et ventes au détail)

Pays couverts

Allemagne, Royaume-Uni, France, Italie, Espagne, Pays-Bas, Russie, Suisse, Turquie, Belgique, reste de l'Europe

Acteurs du marché couverts

BIOMÉRIEUX, Myriad Genetics, Inc., Vela Diagnostics, Abbott, Fujirebio (une société du groupe HU), Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, General Electric, Agilent Technologies, Inc., Biohit Oyj, FOUNDATION MEDICINE, INC., DiaSorin SpA et Paragon Genomics, Inc., QIAGEN entre autres

Définition du marché

Le cancer de l'estomac est un type de cancer qui commence dans l'estomac et se propage dans tout le corps. L'estomac est une poche musculaire située immédiatement sous les côtes dans la partie supérieure de l'abdomen. L'estomac absorbe et retient les aliments que nous mangeons avant de les décomposer et de les digérer. Le cancer de l'estomac, communément appelé cancer gastrique, peut survenir dans n'importe quelle partie de l'estomac. Les cancers de l'estomac se développent dans la partie principale de l'estomac dans la plupart des régions du monde (corps de l'estomac). Divers tests diagnostiques utilisés pour le diagnostic du cancer comprennent des tests de pré-dépistage, une biopsie, des biomarqueurs, des tests d'imagerie, des tomographies par émission de positons (TEP)/tomodensitométrie (CT) et des ultrasons, entre autres.

Le cancer est causé par une prolifération cellulaire anormale et incontrôlée qui a la capacité de se propager et d'envahir d'autres parties du corps. Des changements dans le gène provoquent la croissance et la réplication d'une ou de quelques cellules, ce qui est à l'origine du cancer. Cela peut entraîner la croissance d'une tumeur, qui est une masse anormale de tissu. La création de cellules cancéreuses dans la paroi de l'estomac est connue sous le nom de cancer gastrique ou cancer de l'estomac. L'alimentation et les troubles gastriques sont tous deux des facteurs de risque du cancer gastrique.

Dynamique du marché européen du diagnostic du cancer gastrique

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :    

 Conducteurs

  • Augmentation de l'incidence des tumeurs gastro-intestinales, des lymphomes et des adénocarcinomes

Selon un rapport publié dans Clinical Medicine, le cancer gastrique est le cinquième cancer le plus fréquent et la quatrième cause de décès par cancer dans le monde en 2020. En 2020, on estime que 1,1 million de cas (720 000 hommes et 370 000 femmes) de cancer gastrique ont été diagnostiqués dans le monde. Le cancer gastrique est responsable d'environ 1 décès oncologique sur 12. Chaque année, environ un million de nouveaux cas de cancer de l'estomac sont diagnostiqués dans le monde.

On prévoit que l’incidence du cancer gastrique va augmenter en raison du vieillissement de la population, de l’augmentation du mode de vie et des changements socioéconomiques. Des variations marquées dans la race, les normes socioculturelles, les comportements et les tendances alimentaires se reflètent dans la charge et la répartition du cancer dans différentes régions du monde.

L’incidence croissante des cancers à travers le monde devrait donc accélérer la demande de diagnostics du cancer gastrique. Ainsi, les taux d’incidence accrus des tumeurs gastro-intestinales, des lymphomes et des adénocarcinomes devraient stimuler la croissance du marché européen des diagnostics du cancer gastrique.

  • Hausse de la consommation d'alcool et montée en puissance du tabagisme

Epidemiological, clinical, and laboratory evidence point to a behavioral relationship between cigarette smoking and alcohol consumption. The combined use of cigarettes and alcohol poses health concerns in addition to those posed by smoking alone and so represents a severe public health issue that warrants further investigation.

A chemical chain reaction occurs every time a smoker inhales a lit cigarette, producing dozens of hazardous chemicals. Cigarette smoke contains substances that are inhaled through the lips, through the tongue and mouth, down the throat, and into the lungs, producing inflammation and exposing those bodily parts to cancer-causing chemicals.

Thus, the rise in alcohol consumption and surge in smoking is expected to drive the Europe gastric cancer market growth.

Opportunity

  • Rise in adoption of automated systems

Cancer is a system and network illness. This indicates that in a cancer cell, certain network-related genes stop working properly. Complex interactions in such gene networks should be addressed in cancer treatment. Artificial intelligence (AI) algorithms, in particular, have been rapidly evolving, which is reflected in oncology's progress.

Machine learning and neural networks are becoming increasingly significant in precision oncology and system medicine. The combination of imaging data with clinical and molecular data opens up a world of possibilities. Radiogenomics, for instance, is a new field focused on multidimensional data processing. It can also benefit from AI advancements.

Thus, the increased adoption of automated systems acts as an opportunity for the growth of this market.

Restraint/Challenge

  • Lack of sufficient financial support from health insurance policies

To achieve their objectives, health systems require financial resources. Human resources, hospital care, and medications are the most expensive aspects of most healthcare systems. In most tropical countries, health care is funded through a combination of government, private (mainly out-of-pocket) spending, and international help.

Healthcare finance remains a key concern for low- and lower-middle-income countries. Many upper-middle-income countries in Latin America, Africa, and Asia have been able to establish health finance arrangements that cover large segments of their populations. These measures enable access to health care while also protecting individuals from catastrophic debt incurred as a result of that access. Finance, on the other hand, is a major obstacle to health care delivery in low-income countries (the bulk of which are in Sub-Saharan Africa).

Thus, the lack of sufficient financial support from health insurance policies acts as a restraint to market's growth.

Recent Developments

  • In October 2022, General Electric Company collaborated with several research institutes such as the University of Cambridge Hospitals, Sophia Genetics, and earlier with Optellum to use imaging data in collaboration with Artificial intelligence. This will help to reduce the diagnosing time of several cancers and help to provide personalized care to patients. This has helped the company to widen its horizons in cancer diagnostics
  • In March 2020, Thermo Fisher Scientific Inc. announced that it would be acquiring QIAGEN, a Netherland-based molecular diagnostics and healthcare company. This acquisition by the company will increase its product portfolio in the market, leading to increased revenue in future

Europe Gastric Cancer Diagnostics Market Scope

The Europe gastric cancer diagnostics market is segmented into nine notable segments based on product type, diagnostic type, age group, disease type, stage, gender, sample, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

PRODUCT TYPE

  • Instruments
  • Reagents & Consumables
  • Services

On the basis of product type, the market is segmented into instruments, reagents & consumables, and services.

DIAGNOSTIC TYPE

  • Confirmatory Test
  • Gastric Cancer Screening Tests/Physical Exam

On the basis of diagnostics type, the market is segmented into gastric cancer screening tests/physical exam and confirmatory tests.

AGE GROUP

  • Adult
  • Pediatric
  • Geriatrics

On the basis of age group, the market is segmented into adult, pediatric, and geriatrics.

TYPE

  • Intestinal Or Diffuse Adenocarcinoma
  • Carcinoid Tumor
  • Gastrointestinal Stromal Tumor (GIST)
  • Gastric Lymphoma
  • Others

On the basis of type, the market is segmented into intestinal or diffuse adenocarcinoma, carcinoid tumor, gastrointestinal stromal tumor (GIST), gastric lymphoma, and others.

STAGE

  • Stage 0
  • Stage I
  • Stage II
  • Stage III

On the basis of stage, the market is segmented into stage 0, stage I, stage II, and stage III.

GENDER

  • Male
  • Female

On the basis of gender, the market is segmented into male and female.

SAMPLE TYPE

  • Blood
  • Tissue
  • Urine
  • Stool

On the basis of sample type, the market is segmented into blood, tissue, urine, and stool.

END USER

  • Diagnostic Laboratories
  • Hospitals
  • Cancer Research Institutes
  • Oncology Specialty Clinics
  • Others

On the basis of end users, the market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others.

DISTRIBUTION CHANNEL

  • Direct Tenders
  • Retail Sales

On the basis of distribution channel, the market is segmented into direct tender and retail sales.

Europe Gastric Cancer Diagnostics Market Regional Analysis/Insights

The Europe gastric cancer diagnostics market is segmented into nine notable segments based on product type, diagnostic type, age group, disease type, stage, gender, sample, end user, and distribution channel. 

Les pays couverts dans ce rapport de marché sont l’Allemagne, la France, le Royaume-Uni, la Russie, l’Italie, l’Espagne, la Belgique, les Pays-Bas, la Turquie, la Suisse et le reste de l’Europe.

L’Allemagne devrait dominer le marché européen du diagnostic du cancer gastrique en raison de la prévalence croissante du lymphome et de l’adénocarcinome.

La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie du pays, les actes réglementaires et les tarifs douaniers d'import-export sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques européennes et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché du diagnostic du cancer gastrique

Le paysage concurrentiel du marché européen du diagnostic du cancer gastrique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement du produit, les approbations de produits, la largeur et l'étendue du produit, la domination des applications, la courbe de survie du type de produit. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché du diagnostic du cancer gastrique.

Certains des principaux acteurs opérant sur le marché sont BIOMÉRIEUX, Myriad Genetics, Inc., Vela Diagnostics, Abbott, Fujirebio (une société du groupe HU), Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, General Electric, Agilent Technologies, Inc., Biohit Oyj, FOUNDATION MEDICINE, INC., DiaSorin SpA et Paragon Genomics, Inc., QIAGEN entre autres.

 

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE gastric cancer diagnostics market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. packaging LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET END USER COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. ROLE OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) IN GASTRIC CANCER DIAGNOSTICS
    2. products (brands) Detailed information
  5. REGULATIONS OF EUROPE GASTRIC CANCER DIAGNOSTICS MARKET
  6. Epidemiology
  7. market overview
    1. DRIVERS
      1. INCREASE IN INCIDENCE OF GASTROINTESTINAL TUMOURS, LYMPHOMA, AND ADENOCARCINOMA
      2. RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING
      3. INCREASE IN THE GERIATRIC POPULATION
      4. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      5. RECENT ADVANCES IN GASTRIC CANCER DIAGNOSTICS
    2. RESTRAINTS
      1. HIGH COST OF TESTING
      2. LACK OF SUFFICIENT FINANCIAL SUPPORT FROM HEALTH INSURANCE POLICIES
    3. OPPORTUNITIES
      1. RISING HEALTHCARE SPENDING
      2. ADOPTION OF AUTOMATED SYSTEMS
      3. INCREASED RESEARCH AND DEVELOPMENT ON CANCER DIAGNOSTICS
    4. CHALLENGES
      1. STRINGENT REGULATIONS AND POLICIES FOR APPROVING THE COMPLICATED NATURE OF RADIATION DEVICES
      2. LIMITATIONS OF RADIATION TESTS
  8. IMPACT OF COVID-19 ON EUROPE GASTRIC CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    5. CONCLUSION
  9. Europe gastric cancer diagnostics market, By product type
    1. overview
    2. Reagents & Consumables
      1. Kits
        1. DNA POLYMERASE KITS
        2. PCR KITS
        3. NUCLEIC ACID ISOLATION KITS
        4. OTHERS
      2. Reagents
        1. ASSAYS
        2. BUFFERS
        3. PRIMERS
        4. OTHERS
    3. instruments
    4. services
  10. Europe gastric cancer diagnostics market, By diagnostic type
    1. overview
    2. confirmatory test
      1. imaging tests
        1. PET SCAN/CT SCAN
        2. CT SCAN
        3. ULTRASOUND
        4. MRI
        5. X-RAY
      2. biomarker
        1. DNA BIOMARKER
        2. RNA BIOMARKER
        3. PROTEIN BIOMARKER
      3. biopsy
    3. gastric cancer screening tests/physical exam
  11. Europe gastric cancer diagnostics market, By age group
    1. overview
    2. geriatrics
    3. adult
    4. pediatric
  12. Europe gastric cancer diagnostics market, By disease type
    1. overview
    2. intestinal or diffuse adenocarcinoma
    3. carcinoid tumor
    4. gastrointestinal stromal tumor
    5. gastric lymphoma
    6. others
  13. Europe gastric cancer diagnostics market, By stage
    1. overview
    2. stage i
      1. stage iA
      2. stage iB
    3. stage iI
      1. stage IiA
      2. stage IiB
    4. stage iII
      1. stage IiIA
      2. stage IiIB
      3. stage IiIC
    5. stage 0
  14. Europe gastric cancer diagnostics market, By GENDER
    1. overview
    2. male
    3. female
  15. Europe gastric cancer diagnostics market, By sample type
    1. overview
    2. stool
    3. tissue
    4. blood
    5. urine
  16. Europe gastric cancer diagnostics market, By end user
    1. overview
    2. hospitals
    3. diagnostic laboratories
    4. cancer research institutes
    5. oncology specialty clinics
    6. others
  17. Europe gastric cancer diagnostics market, By distribution channel
    1. overview
    2. direct tenders
    3. Retail Sales
  18. EUROPE gastric cancer diagnostics MARKET, BY REGION
    1. EUROPE
      1. Germany
      2. France
      3. U.K.
      4. Russia
      5. Italy
      6. Spain
      7. Belgium
      8. Netherlands
      9. Turkey
      10. Switzerland
      11. Rest of Europe
  19. EUROPE Gastric Cancer diagnostics Market: COMPANY landscape
    1. company share analysis: Europe
  20. SWOT
  21. Company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. GENERAL ELECTRIC COMPANY
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. BIOMÉRIEUX SA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. ACON Laboratories, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. ADVACARE PHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. AGILENT TECHNOLOGIES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. BIOCEPT, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Biohit Oyj
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. DiaSorin S.p.A
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. Endofotonics Pte Ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. foundation medicine, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. fujirebio (an h.u. group company)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. MiRXES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Paragon Genomics, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. qiagen
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    18. teco diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. vela diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  22. questionnaire
  23. related reports

Liste des tableaux

TABLE 1 Europe gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 2 Europe reagents & consumables in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 3 Europe Reagent and consumables IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 4 Europe kits IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 5 Europe reagents IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 6 Europe instruments in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe services in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 8 Europe gastric cancer diagnostics market, By diagnostic type, 2019-2028 (USD million)

TABLE 9 Europe confirmatory test in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 10 Europe confirmatory test in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 11 Europe imaging tests in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 12 Europe biomarker in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 13 Europe gastric cancer screening tests/physical exam in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe gastric cancer diagnostics market, By age group, 2019-2028 (USD million)

TABLE 15 Europe geriatrics in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 16 Europe adult in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 17 Europe pediatric in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 18 Europe gastric cancer diagnostics market, By disease type, 2019-2028 (USD million)

TABLE 19 Europe intestinal or diffuse ADENOCARCINOMA in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 20 Europe carcinoid tumor in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe gastrointestinal stromal tumor in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe gastric lymphoma in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe others in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe gastric cancer diagnostics market, By stage, 2019-2028 (USD million)

TABLE 25 Europe stage i in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 26 Europe stage i in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 27 Europe stage iI in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe stage iI in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 29 Europe stage iII in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 30 Europe stage iIi in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 31 Europe stage 0 in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 32 Europe gastric cancer diagnostics market, By gender, 2019-2028 (USD million)

TABLE 33 Europe male in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 34 Europe female in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 35 Europe gastric cancer diagnostics market, By sample type, 2019-2028 (USD million)

TABLE 36 Europe stool in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 37 Europe tissue in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 38 Europe blood in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 39 Europe urine in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 40 Europe gastric cancer diagnostics market, By end user, 2019-2028 (USD million)

TABLE 41 Europe HOSPITALS in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe diagnostic laboratories in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 43 Europe cancer research institutes in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 44 Europe oncology specialty clinics in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 45 Europe others in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 46 Europe gastric cancer diagnostics market, By distribution channel, 2019-2028 (USD million)

TABLE 47 Europe direct tenders in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 48 Europe Retail Sales in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 49 EUROPE Gastric Cancer Diagnostics Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 50 Europe Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 51 Europe Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 52 Europe Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 53 Europe Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 54 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 55 Europe Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 56 Europe Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 57 Europe Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 58 Europe Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 59 Europe Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 60 Europe Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 61 Europe Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 62 Europe Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 63 Europe Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 64 Europe Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 65 Europe Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 66 Europe Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 67 Europe Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 68 Germany Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 69 Germany Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 70 Germany Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 71 Germany Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 72 Germany Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 73 Germany Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 74 Germany Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 75 Germany Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 76 Germany Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 77 Germany Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 78 Germany Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 79 Germany Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 80 Germany Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 81 Germany Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 82 Germany Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 83 Germany Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 84 Germany Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 85 Germany Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 86 France Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 87 France Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 88 France Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 89 France Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 90 France Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 91 France Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 92 France Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 93 France Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 94 France Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 95 France Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 96 France Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 97 France Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 98 France Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 99 France Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 100 France Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 101 France Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 102 France Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 103 France Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 104 U.K. Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 105 U.K. Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 106 U.K. Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 107 U.K. Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 108 U.K. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 109 U.K. Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 110 U.K. Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 111 U.K. Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 112 U.K. Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 113 U.K. Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 114 U.K. Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 115 U.K. Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 116 U.K. Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 117 U.K. Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 118 U.K. Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 119 U.K. Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 120 U.K. Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 121 U.K. Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 122 Russia Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 123 Russia Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 124 Russia Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 125 Russia Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 126 Russia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 127 Russia Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 128 Russia Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 129 Russia Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 130 Russia Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 131 Russia Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 132 Russia Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 133 Russia Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 134 Russia Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 135 Russia Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 136 Russia Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 137 Russia Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 138 Russia Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 139 Russia Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 140 Italy Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 141 Italy Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 142 Italy Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 143 Italy Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 144 Italy Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 145 Italy Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 146 Italy Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 147 Italy Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 148 Italy Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 149 Italy Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 150 Italy Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 151 Italy Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 152 Italy Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 153 Italy Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 154 Italy Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 155 Italy Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 156 Italy Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 157 Italy Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 158 Spain Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 159 Spain Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 160 Spain Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 161 Spain Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 162 Spain Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 163 Spain Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 164 Spain Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 165 Spain Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 166 Spain Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 167 Spain Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 168 Spain Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 169 Spain Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 170 Spain Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 171 Spain Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 172 Spain Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 173 Spain Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 174 Spain Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 175 Spain Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 176 Belgium Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 177 Belgium Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 178 Belgium Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 179 Belgium Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 180 Belgium Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 181 Belgium Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 182 Belgium Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 183 Belgium Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 184 Belgium Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 185 Belgium Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 186 Belgium Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 187 Belgium Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 188 Belgium Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 189 Belgium Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 190 Belgium Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 191 Belgium Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 192 Belgium Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 193 Belgium Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 194 Netherlands Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 195 Netherlands Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 196 Netherlands Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 197 Netherlands Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 198 Netherlands Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 199 Netherlands Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 200 Netherlands Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 201 Netherlands Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 202 Netherlands Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 203 Netherlands Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 204 Netherlands Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 205 Netherlands Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 206 Netherlands Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 207 Netherlands Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 208 Netherlands Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 209 Netherlands Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 210 Netherlands Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 211 Netherlands Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 212 Turkey Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 213 Turkey Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 214 Turkey Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 215 Turkey Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 216 Turkey Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 217 Turkey Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 218 Turkey Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 219 Turkey Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 220 Turkey Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 221 Turkey Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 222 Turkey Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 223 Turkey Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 224 Turkey Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 225 Turkey Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 226 Turkey Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 227 Turkey Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 228 Turkey Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 229 Turkey Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 230 Switzerland Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 231 Switzerland Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 232 Switzerland Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 233 Switzerland Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 234 Switzerland Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 235 Switzerland Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 236 Switzerland Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 237 Switzerland Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 238 Switzerland Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 239 Switzerland Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 240 Switzerland Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 241 Switzerland Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 242 Switzerland Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 243 Switzerland Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 244 Switzerland Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 245 Switzerland Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 246 Switzerland Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 247 Switzerland Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 248 Rest of Europe Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 Europe GASTRIC CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 Europe Gastric cancer diagnostics market: DROC ANALYSIS

FIGURE 4 Europe Gastric cancer diagnostics market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Gastric cancer diagnostics market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Gastric cancer diagnostics market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Gastric cancer diagnostics market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE gastric cancer diagnostics market: MARKET END USER COVERAGE GRID

FIGURE 11 Europe Gastric cancer diagnostics market: SEGMENTATION

FIGURE 12 Increase in incidence of gastrointestinal tumors, lymphoma, and adenocarcinoma is expected to DRIVe THE Europe Gastric cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 reagents and consumables SEGMENT is expected to account for the largest share of the Europe GASTRIC CANCER DIAGNOSTICS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe Gastric cancer diagnostics Market

FIGURE 15 Europe gastric cancer diagnostics market: By product type, 2020

FIGURE 16 Europe gastric cancer diagnostics market: By product type, 2021-2028 (USD Million)

FIGURE 17 Europe gastric cancer diagnostics market: By product type, CAGR (2021-2028)

FIGURE 18 Europe gastric cancer diagnostics market: By product type, LIFELINE CURVE

FIGURE 19 Europe gastric cancer diagnostics market: By diagnostic type, 2020

FIGURE 20 Europe gastric cancer diagnostics market: By diagnostic type, 2021-2028 (USD Million)

FIGURE 21 Europe gastric cancer diagnostics market: By diagnostic type, CAGR (2021-2028)

FIGURE 22 Europe gastric cancer diagnostics market: By diagnostic type, LIFELINE CURVE

FIGURE 23 Europe gastric cancer diagnostics market: By age group, 2020

FIGURE 24 Europe gastric cancer diagnostics market: By age group, 2021-2028 (USD Million)

FIGURE 25 Europe gastric cancer diagnostics market: By age group, CAGR (2021-2028)

FIGURE 26 Europe gastric cancer diagnostics market: By age group, LIFELINE CURVE

FIGURE 27 Europe gastric cancer diagnostics market: By disease type, 2020

FIGURE 28 Europe gastric cancer diagnostics market: By disease type, 2021-2028 (USD Million)

FIGURE 29 Europe gastric cancer diagnostics market: By disease type, CAGR (2021-2028)

FIGURE 30 Europe gastric cancer diagnostics market: By disease type, LIFELINE CURVE

FIGURE 31 Europe gastric cancer diagnostics market: By stage, 2020

FIGURE 32 Europe gastric cancer diagnostics market: By stage, 2021-2028 (USD Million)

FIGURE 33 Europe gastric cancer diagnostics market: By stage, CAGR (2021-2028)

FIGURE 34 Europe gastric cancer diagnostics market: By stage, LIFELINE CURVE

FIGURE 35 Europe gastric cancer diagnostics market: By gender, 2020

FIGURE 36 Europe gastric cancer diagnostics market: By gender, 2021-2028 (USD Million)

FIGURE 37 Europe gastric cancer diagnostics market: By gender, CAGR (2021-2028)

FIGURE 38 Europe gastric cancer diagnostics market: By gender, LIFELINE CURVE

FIGURE 39 Europe gastric cancer diagnostics market: By sample type, 2020

FIGURE 40 Europe gastric cancer diagnostics market: By sample type, 2021-2028 (USD Million)

FIGURE 41 Europe gastric cancer diagnostics market: By sample type, CAGR (2021-2028)

FIGURE 42 Europe gastric cancer diagnostics market: By sample type, LIFELINE CURVE

FIGURE 43 Europe gastric cancer diagnostics market: By end user, 2020

FIGURE 44 Europe gastric cancer diagnostics market: By end user, 2021-2028 (USD Million)

FIGURE 45 Europe gastric cancer diagnostics market: By end user, CAGR (2021-2028)

FIGURE 46 Europe gastric cancer diagnostics market: By end user, LIFELINE CURVE

FIGURE 47 Europe gastric cancer diagnostics market: By distribution channel, 2020

FIGURE 48 Europe gastric cancer diagnostics market: By distribution channel, 2021-2028 (USD Million)

FIGURE 49 Europe gastric cancer diagnostics market: By distribution channel, CAGR (2021-2028)

FIGURE 50 Europe gastric cancer diagnostics market: By distribution channel, LIFELINE CURVE

FIGURE 51 EUROPE Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 52 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 53 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 54 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 EUROPE Gastric Cancer Diagnostics MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 56 Europe Gastric Cancer diagnostics Market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Europe Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.1% during the forecast period by 2030.
The future market value of the Europe Gastric Cancer Diagnostics Market is expected to reach USD 428.98 million by 2030.
The major players in the Europe Gastric Cancer Diagnostics Market are BIOMÉRIEUX, Myriad Genetics, Inc., Vela Diagnostics, Abbott, Fujirebio (An H.U. Group company), Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, General Electric, Agilent Technologies, Inc., etc.
The countries covered in the Europe Gastric Cancer Diagnostics Market are Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, rest of Europe.

Parcourir les pages associées

Banner